Dietary saturated fatty acids reverse inflammatory and fibrotic changes in rat liver despite continued ethanol administration

被引:7
作者
Nanji, AA
Jokelainen, K
Tipoe, GL
Rahemtulla, A
Dannenberg, AJ
机构
[1] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China
[2] Univ Hong Kong, Ctr Study Liver Dis, Hong Kong, Hong Kong, Peoples R China
[3] Univ Helsinki, Cent Hosp, Alcohol Dis Res Unit, Helsinki, Finland
[4] Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China
[5] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
[6] Cornell Univ, Weill Med Coll, Dept Med, New York, NY USA
[7] Strong Canc Prevent Ctr, Anne Fisher Nutr Ctr, New York, NY USA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
We investigated the potential of dietary saturated fatty acids to reverse alcoholic liver injury despite continued administration of alcohol. Five groups (six rats/group) of male Wistar rats were studied. Rats in groups 1 and 2 were fed a fish oil-ethanol diet for 8 and 6 weeks, respectively. Rats in groups 3 and 4 were fed fish oil and ethanol for 6 weeks before being switched to isocaloric diets containing ethanol with palm oil (group 3) or medium-chain triglycerides (MCTs, group 4) for 2 weeks. Rats in group 5 were fed fish oil and dextrose for 8 weeks. Liver samples were analyzed for histopathology, lipid peroxidation, nuclear factor-kappaB (NF-kappaB) activation, and mRNAs for cyclooxygenase-2 (Cox-2) and tumor necrosis factor-alpha (TNF-alpha). Endotoxin in plasma was determined. The most severe inflammation and fibrosis were detected in groups 1 and 2, as were the highest levels of endotoxin, lipid peroxidation, activation of NF-kappaB, and mRNAs for Cox-2 and TNF-alpha. After the rats were switched to palm oil or MCT, there was marked histological improvement with decreased levels of endotoxin and lipid peroxidation, absence of NF-kappaB activation, and reduced expression of TNF-alpha and Cox-2. A diet enriched in saturated fatty acids effectively reverses alcohol-induced necrosis, inflammation, and fibrosis despite continued alcohol consumption. The therapeutic effects of saturated fatty acids may be explained, at least in part, by reduced endotoxemia and lipid peroxidation, which in turn result in decreased activation of NF-kappaB and reduced levels of TNF-alpha and Cox-2.
引用
收藏
页码:638 / 644
页数:7
相关论文
共 40 条
[1]
ANTIBIOTICS PREVENT LIVER-INJURY IN RATS FOLLOWING LONG-TERM EXPOSURE TO ETHANOL [J].
ADACHI, Y ;
MOORE, LE ;
BRADFORD, BU ;
GAO, WS ;
THURMAN, RG .
GASTROENTEROLOGY, 1995, 108 (01) :218-224
[2]
Albano E, 1996, HEPATOLOGY, V23, P155, DOI 10.1053/jhep.1996.v23.pm0008550035
[3]
SPECTROPHOTOMETRIC STUDY OF SEVERAL SENSITIVE REAGENTS FOR SERUM IRON [J].
ARTISS, JD ;
VINOGRADOV, S ;
ZAK, B .
CLINICAL BIOCHEMISTRY, 1981, 14 (06) :311-315
[4]
Mechanisms of disease - Nuclear factor-kappa b - A pivotal transcription factor in chronic inflammatory diseases [J].
Barnes, PJ ;
Larin, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (15) :1066-1071
[5]
SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[6]
EFFECT OF ETHANOL ON CYTOCHROME-P450-2E1 (CYP2E1), LIPID-PEROXIDATION, AND SERUM-PROTEIN ADDUCT FORMATION IN RELATION TO LIVER PATHOLOGY PATHOGENESIS [J].
FRENCH, SW ;
WONG, K ;
JUI, L ;
ALBANO, E ;
HAGBJORK, AL ;
INGELMANSUNDBERG, M .
EXPERIMENTAL AND MOLECULAR PATHOLOGY, 1993, 58 (01) :61-75
[7]
ETHANOL-INDUCED HEPATIC-FIBROSIS IN THE RAT - ROLE OF THE AMOUNT OF DIETARY-FAT [J].
FRENCH, SW ;
MIYAMOTO, K ;
TSUKAMOTO, H .
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1986, 10 (06) :S13-S19
[8]
Lipid peroxidation, CYP2E1 and arachidonic acid metabolism in alcoholic liver disease in rats [J].
French, SW ;
Morimoto, M ;
Reitz, RC ;
Koop, D ;
Klopfenstein, B ;
Estes, K ;
Clot, P ;
IngelmanSundberg, M ;
Albano, E .
JOURNAL OF NUTRITION, 1997, 127 :S907-S911
[9]
RATIONALE FOR THERAPY FOR ALCOHOLIC LIVER-DISEASE [J].
FRENCH, SW .
GASTROENTEROLOGY, 1995, 109 (02) :617-620
[10]
FULTON S, 1998, CLIN LIVER DIS, V2, P779